SMTL ID : 5sca.2 (1 other biounit)

Structure of liver pyruvate kinase in complex with anthraquinone derivative 36

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.92 Å

Oligo State

homo-tetramer

Ligands

4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)

FBP.1: 16 residues within 4Å: Chain A: L.347, T.348, T.349, T.350, R.352, S.353, W.398, R.405, G.430, R.432, P.433, G.434, S.435, G.436, Y.437, T.438 19 PLIP interactions: 19 interactions with chain A Hydrogen bonds: A:T.348, A:T.349, A:T.349, A:T.350, A:S.353, A:S.353, A:G.430, A:R.432, A:R.432, A:G.434, A:G.436, A:Y.437 Water bridges: A:L.347, A:D.401, A:R.405, A:R.405, A:R.405, A:G.430 Salt bridges: A:R.405 FBP.6: 16 residues within 4Å: Chain B: L.347, T.348, T.349, T.350, R.352, S.353, W.398, R.405, G.430, R.432, P.433, G.434, S.435, G.436, Y.437, T.438 17 PLIP interactions: 17 interactions with chain B Hydrogen bonds: B:T.348, B:T.349, B:T.350, B:S.353, B:S.353, B:G.430, B:R.432, B:G.434, B:S.435, B:G.436, B:Y.437 Water bridges: B:T.349, B:T.349, B:R.405, B:R.405, B:T.438 Salt bridges: B:R.405 FBP.11: 17 residues within 4Å: Chain C: L.347, T.348, T.349, T.350, R.352, S.353, W.398, R.405, T.429, G.430, R.432, P.433, G.434, S.435, G.436, Y.437, T.438 16 PLIP interactions: 16 interactions with chain C Hydrogen bonds: C:T.348, C:T.349, C:T.350, C:S.353, C:G.430, C:R.432, C:G.434, C:S.435, C:G.436, C:Y.437 Water bridges: C:T.349, C:R.405, C:R.405, C:T.438, C:T.438 Salt bridges: C:R.405 FBP.15: 16 residues within 4Å: Chain D: L.347, T.348, T.349, T.350, R.352, S.353, W.398, R.405, G.430, R.432, P.433, G.434, S.435, G.436, Y.437, T.438 21 PLIP interactions: 21 interactions with chain D Hydrogen bonds: D:T.348, D:T.348, D:T.349, D:T.349, D:T.350, D:G.351, D:S.353, D:S.353, D:G.430, D:R.432, D:G.434, D:G.436, D:Y.437 Water bridges: D:L.347, D:L.347, D:R.371, D:R.371, D:R.405, D:R.405, D:R.405 Salt bridges: D:R.405

4 x OXL: OXALATE ION(Non-covalent)

OXL.2: 8 residues within 4Å: Chain A: K.186, E.188, A.209, R.210, G.211, D.212, T.244 Ligands: MG.4 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:G.211, A:D.212, A:D.212 Water bridges: A:K.186 Salt bridges: A:R.87, A:K.186 OXL.8: 8 residues within 4Å: Chain B: K.186, E.188, A.209, R.210, G.211, D.212, T.244 Ligands: MG.9 8 PLIP interactions: 8 interactions with chain B Hydrogen bonds: B:G.211, B:D.212, B:T.244, B:T.244, B:T.244 Water bridges: B:K.186 Salt bridges: B:R.87, B:K.186 OXL.12: 8 residues within 4Å: Chain C: K.186, E.188, A.209, R.210, G.211, D.212, T.244 Ligands: MG.13 10 PLIP interactions: 10 interactions with chain C Hydrogen bonds: C:G.211, C:D.212, C:D.212, C:T.244, C:T.244, C:T.244 Water bridges: C:K.186 Salt bridges: C:R.87, C:K.186, C:K.186 OXL.16: 8 residues within 4Å: Chain D: K.186, E.188, A.209, R.210, G.211, D.212, T.244 Ligands: MG.17 8 PLIP interactions: 8 interactions with chain D Hydrogen bonds: D:E.188, D:E.188, D:G.211, D:D.212 Water bridges: D:R.87, D:K.186 Salt bridges: D:R.87, D:K.186

2 x I7N: N-[(3R)-1-(3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonyl)piperidine-3-carbonyl]-L-aspartic acid(Non-covalent)

I7N.3: 13 residues within 4Å: Chain A: T.64, P.67, R.87, N.89, S.91, H.92, G.93, Y.97, H.98, S.278, G.279, A.282, K.283 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:P.67, A:H.92, A:Y.97, A:A.282 Hydrogen bonds: A:R.87, A:N.89, A:S.91, A:K.283, A:K.283 Water bridges: A:N.89, A:K.186 Salt bridges: A:H.92 pi-Cation interactions: A:H.92 I7N.7: 14 residues within 4Å: Chain B: T.64, P.67, R.87, N.89, S.91, H.92, G.93, Y.97, H.98, S.278, G.279, A.282, K.283 Ligands: K.10 15 PLIP interactions: 15 interactions with chain B Hydrophobic interactions: B:P.67, B:H.92, B:Y.97, B:A.282, B:K.283 Hydrogen bonds: B:R.87, B:N.89, B:N.89, B:S.91 Water bridges: B:N.89, B:G.279 Salt bridges: B:H.92, B:H.92 pi-Cation interactions: B:H.92, B:H.92

4 x MG: MAGNESIUM ION(Non-covalent)

MG.4: 3 residues within 4Å: Chain A: E.188, D.212 Ligands: OXL.2 4 PLIP interactions: 2 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:E.188, A:D.212, H2O.2, H2O.4 MG.9: 3 residues within 4Å: Chain B: E.188, D.212 Ligands: OXL.8 4 PLIP interactions: 2 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:E.188, B:D.212, H2O.11, H2O.12 MG.13: 3 residues within 4Å: Chain C: E.188, D.212 Ligands: OXL.12 4 PLIP interactions: 2 interactions with chain C, 2 Ligand-Water interactions Metal complexes: C:E.188, C:D.212, H2O.22, H2O.25 MG.17: 3 residues within 4Å: Chain D: E.188, D.212 Ligands: OXL.16 4 PLIP interactions: 2 interactions with chain D, 2 Ligand-Water interactions Metal complexes: D:E.188, D:D.212, H2O.37, H2O.38

4 x K: POTASSIUM ION(Non-covalent)

K.5: 5 residues within 4Å: Chain A: N.89, S.91, D.127, T.128, S.159 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:S.91, A:D.127, A:T.128 K.10: 6 residues within 4Å: Chain B: N.89, S.91, D.127, T.128, S.159 Ligands: I7N.7 3 PLIP interactions: 3 interactions with chain B Metal complexes: B:S.91, B:D.127, B:T.128 K.14: 6 residues within 4Å: Chain C: N.89, S.91, D.127, T.128, S.159, K.186 4 PLIP interactions: 3 interactions with chain C, 1 Ligand-Water interactions Metal complexes: C:S.91, C:D.127, C:T.128, H2O.28 K.18: 6 residues within 4Å: Chain D: N.89, S.91, D.127, T.128, S.159, K.186 5 PLIP interactions: 3 interactions with chain D, 2 Ligand-Water interactions Metal complexes: D:S.91, D:D.127, D:T.128, H2O.44, H2O.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nain-Perez, A. et al., Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase. Eur.J.Med.Chem. (2022)

Release Date

2022-03-16

Peptides

Pyruvate kinase: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
F

C
G

D
H

Pyruvate kinase

Related Entries With Identical Sequence